Global Losartan
At cognitive, a dedicated team has worked on this report, we have disclosed one of the team member involved in the publication and client consultation process for your reference. You can initiate the discussion her via Book an appointment
At cognitive, our research analyst works closely with Losartan market experts to validate the gathered data and have the expert's opinion available for our clients. You can book a consultation call with our research analyst and industry experts on board (Subject to time availability and paid consultation services)
The base year for the analysis is 2025. Historical data has been considered for the period from 2022 to 2025. The year 2026 is considered as the estimated base for forecasting, with projections covering the period from 2026 to 2034. When we deliver the report that time we updated report data till the purchase date.
From the database of Cognitive, this is an unique identification number of reports and it will also have different reports associated with it.
Report edition's total number of pages for pdf format (Approximate)
Rating and review received by the reader or subscriber of the said report.
Athenaeum Visualization Dashboard: Access your purchased data/Report/Service through a sophisticated, interactive interface. The Athenaeum Dashboard allows you to preview data/reports and store them in a customizable dashboard, enabling you to filter metrics and uncover deeper trends specific to your enterprise needs.
PDF Access: To ensure the highest level of data integrity and confidentiality, your premium report editions are delivered as password-protected PDF files. These are securely shared via email and remain accessible within your dedicated Athenaeum account for future reference.
Versatile Multi-Format Export (Excel & MS Word): We provide the flexibility to integrate our research directly into your internal workflows. Upon request, relevant quantitative data and qualitative insights from your purchased reports can be provided in fully editable Microsoft Excel and Word formats.
Multiple Cloud Accounts: Benefit from a dedicated, encrypted cloud account that ensures your market intelligence is available on-demand. Access your research from any device, at any time, and from any location. Multiple Accounts facilitating seamless collaboration across your collegue or whole organization.
Athenaeum AI Assistant(Value-Added Service): Elevate your research capabilities with Athenaeum AI Assistant, our proprietary 24/7 research assistant. Equivalent in depth to a dedicated research analyst, this AI-driven tool provides round-the-clock data support and instant insights to help you navigate complex market landscapes in real-time.
As Cognitive a market research and consulting firm, we can provide Losartan market Analysis and consultation services with the help of our data collection processes and Proprietary research methodology called Full Truth. We have in-house team of research analysts and network of industry experts on board. In fact, we provided high-impact consualtion services to the listed client in competitior analysis. As an extension of our bespoke consulting engagements, we also provide access to Proprietary datasets of market analysis publish, making authoritative industry intelligence accessible to the public domain.
Losartan Market Analysis 2026
Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence. along with Report Access and Athenaeum Dashboard Subscription — Revenue, Volume, Production, Trade Analysis, value chain and supply chain analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022-2025 | Base Year: 2025 | Forecast Period: 2026-2034 |
|---|---|
| Dosage Form Segment Analysis | Tablet, Powder, Suspension |
| Application Segment Analysis | Hypertension, Stroke, Diabetic Nephropathy, Others |
| Distribution Channel Segment Analysis | Contract Manufacturing, In-house Manufacturing, Others |
|---|---|
| Regions & Countries Analysis |
|
Share your contact details to receive free updated sample copy/pages of the recently published edition of Losartan Market Report 2025.
Global Losartan Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends
Top 10 Countries Losartan Market Analysis includes Ranking, Market Size, Revenue in Million, Market Volume Unit
Top 10 Countries Analysis of Losartan Market Share Distribution
According to Cognitive Market Research, the global Losartan market size was USD 1625.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 4.50% from 2024 to 2031.
- North America held the major market share for more than 40% of the global revenue with a market size of USD 650.20 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031.
- Europe accounted for a market share of over 30% of the global revenue with a market size of USD 487.65 million.
- Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 373.87 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
- Latin America had a market share of more than 5% of the global revenue with a market size of USD 81.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031.
- Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 32.51 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.
- The Contract Manufacturing category is the fastest growing segment of the Losartan industry
Market Drivers:
|
Market Restrains:
|
Market Trends:
|
| Market Size | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global Losartan Market Sales Revenue | $ 1567.02 Million | $ 1873 Million | $ 2675.85 Million | 4.56% |
| North America Losartan Market Sales Revenue | $ 586.067 Million | $ 679.899 Million | $ 915.142 Million | 3.784% |
| United States Losartan Market Sales Revenue | $ 444.825 Million | $ 509.924 Million | $ 668.054 Million | 3.434% |
| Canada Losartan Market Sales Revenue | $ 87.324 Million | $ 106.064 Million | $ 155.574 Million | 4.905% |
| Mexico Losartan Market Sales Revenue | $ 53.918 Million | $ 63.911 Million | $ 91.514 Million | 4.59% |
| Europe Losartan Market Sales Revenue | $ 434.065 Million | $ 511.329 Million | $ 706.425 Million | 4.123% |
| United Kingdom Losartan Market Sales Revenue | $ 72.055 Million | $ 88.971 Million | $ 135.634 Million | 5.412% |
| France Losartan Market Sales Revenue | $ 43.407 Million | $ 51.133 Million | $ 71.349 Million | 4.252% |
| Germany Losartan Market Sales Revenue | $ 90.286 Million | $ 109.936 Million | $ 161.771 Million | 4.947% |
| Italy Losartan Market Sales Revenue | $ 40.802 Million | $ 48.576 Million | $ 69.23 Million | 4.528% |
| Russia Losartan Market Sales Revenue | $ 64.676 Million | $ 73.631 Million | $ 93.955 Million | 3.094% |
| Spain Losartan Market Sales Revenue | $ 26.044 Million | $ 29.708 Million | $ 38.147 Million | 3.175% |
| Rest of Europe Losartan Market Sales Revenue | $ 25.523 Million | $ 29.606 Million | $ 37.441 Million | 2.978% |
| Sweden Losartan Market Sales Revenue | $ 19.533 Million | $ 21.987 Million | $ 28.963 Million | 3.505% |
| Denmark Losartan Market Sales Revenue | $ 25.697 Million | $ 29.146 Million | $ 36.028 Million | 2.685% |
| Switzerland Losartan Market Sales Revenue | $ 17.363 Million | $ 18.919 Million | $ 22.606 Million | 2.25% |
| Luxembourg Losartan Market Sales Revenue | $ 8.681 Million | $ 9.715 Million | $ 11.303 Million | 1.91% |
| Asia Pacific Losartan Market Sales Revenue | $ 321.24 Million | $ 408.314 Million | $ 652.908 Million | 6.043% |
| China Losartan Market Sales Revenue | $ 129.781 Million | $ 166.592 Million | $ 267.04 Million | 6.076% |
| Japan Losartan Market Sales Revenue | $ 52.683 Million | $ 64.514 Million | $ 96.63 Million | 5.18% |
| India Losartan Market Sales Revenue | $ 39.191 Million | $ 53.897 Million | $ 100.548 Million | 8.106% |
| South Korea Losartan Market Sales Revenue | $ 30.839 Million | $ 37.973 Million | $ 57.456 Million | 5.313% |
| Australia Losartan Market Sales Revenue | $ 17.347 Million | $ 23.274 Million | $ 41.133 Million | 7.378% |
| Rest of APAC Losartan Market Sales Revenue | xxxx | xxxx | xxxx | 6.3% |
| Singapore Losartan Market Sales Revenue | $ 11.565 Million | $ 13.883 Million | $ 20.24 Million | 4.826% |
| South East Asia Losartan Market Sales Revenue | $ 15.098 Million | $ 18.782 Million | $ 28.075 Million | 5.153% |
| Taiwan Losartan Market Sales Revenue | $ 10.601 Million | $ 12.658 Million | $ 18.934 Million | 5.163% |
| South America Losartan Market Sales Revenue | $ 108.125 Million | $ 131.11 Million | $ 192.661 Million | 4.929% |
| Brazil Losartan Market Sales Revenue | $ 40.979 Million | $ 50.74 Million | $ 77.257 Million | 5.396% |
| Argentina Losartan Market Sales Revenue | $ 20.003 Million | $ 24.937 Million | $ 38.34 Million | 5.524% |
| Colombia Losartan Market Sales Revenue | $ 9.623 Million | $ 11.275 Million | $ 15.606 Million | 4.146% |
| Peru Losartan Market Sales Revenue | $ 8.758 Million | $ 10.489 Million | $ 14.835 Million | 4.429% |
| Chile Losartan Market Sales Revenue | $ 7.244 Million | $ 8.784 Million | $ 12.716 Million | 4.732% |
| Rest of South America Losartan Market Sales Revenue | $ 21.517 Million | $ 24.885 Million | $ 33.908 Million | 3.943% |
| Middle East Losartan Market Sales Revenue | $ 68.949 Million | $ 80.539 Million | $ 112.386 Million | 4.253% |
| Egypt Losartan Market Sales Revenue | $ 7.515 Million | $ 8.618 Million | $ 11.463 Million | 3.631% |
| Turkey Losartan Market Sales Revenue | $ 14.893 Million | $ 17.316 Million | $ 23.826 Million | 4.07% |
| Rest of Middle East Losartan Market Sales Revenue | $ 4.826 Million | $ 5.316 Million | $ 6.518 Million | 2.583% |
| Saudi Arabia Losartan Market Sales Revenue | $ 28.476 Million | $ 33.585 Million | $ 47.876 Million | 4.532% |
| UAE Losartan Market Sales Revenue | $ 9.032 Million | $ 11.114 Million | $ 17.195 Million | 5.606% |
| Qatar Losartan Market Sales Revenue | $ 4.206 Million | $ 4.591 Million | $ 5.507 Million | 2.301% |
| Africa Losartan Market Sales Revenue | $ 48.578 Million | $ 61.809 Million | $ 96.331 Million | 5.703% |
| South Africa Losartan Market Sales Revenue | $ 19.188 Million | $ 23.858 Million | $ 35.257 Million | 5.003% |
| Nigeria Losartan Market Sales Revenue | $ 12.825 Million | $ 16.75 Million | $ 27.454 Million | 6.371% |
Losartan Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Losartan Market Report Description
Introduction of the Losartan Market
Losartan is an angiotensin II receptor blocker (ARB) that is primarily employed to manage hypertension (high blood pressure). It operates by relaxing blood vessels, which facilitates the flow of blood and contributes to the reduction of blood pressure. Losartan is also prescribed to mitigate the risk of stroke in patients with hypertension and left ventricular hypertrophy, as well as to address kidney complications in individuals with diabetes. It is available in oral tablet form and is marketed under brand names such as Cozaar, as well as in generic versions. It is anticipated that the global losartan market will expand rapidly. The global rise in the incidence of hypertension, stroke, and diabetic nephropathy is stimulating the market. The demand for losartan is further fueled by the increasing awareness of cardiovascular health and the ageing population.
In September 2023, Granules India Limited has announced that the US FDA has approved its Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide Tablets USP, in a variety of dosages. These tablets are bioequivalent to the reference drug, Hyzaar, and are prescribed for the treatment of hypertension and the mitigation of stroke risk in patients with hypertension and left ventricular hypertrophy. Granules India has now received a total of 60 ANDA approvals from the US FDA as a result of this approval. The current annual market for these tablets in the United States is approximately $73 million. (Source: https://granulesindia.com/wp-content/uploads/2023/10/Press-Release-Losartan-HCTZ-Tabs-PR.pdf)
Losartan Market Size
Market Dynamics of Losartan Market
Key Drivers for Losartan Market
Expanding Elderly Population Driving Demand: As the global population of elderly individuals increases, so does the incidence of age-related ailments such as hypertension and frailty. Research indicates that losartan not only manages blood pressure effectively but also enhances physical function and diminishes frailty, rendering it extremely beneficial for older adults. This demographic shift is directly enhancing market demand.
Rising Incidence of Hypertension: With more than 1.3 billion individuals affected worldwide, hypertension represents a significant health challenge. Losartan is frequently prescribed due to its proven ability to lower blood pressure and decrease the risk of stroke, particularly in patients with cardiac enlargement, thereby propelling its global utilization and market expansion.
Restraint Factor for the Losartan Market
Adverse Effects and Tolerability Concerns: Although losartan is effective, it may lead to side effects such as dizziness, fatigue, and gastrointestinal disturbances. These issues can result in non-adherence or cessation of treatment, especially among older patients or those with multiple health conditions. Tailored treatment approaches and diligent patient monitoring are crucial to address this limitation.
Key Trends for Losartan Market
Growing Preference for ARB-Based Combination Therapies: Healthcare professionals are increasingly opting to prescribe losartan alongside diuretics or calcium channel blockers to enhance effectiveness and streamline hypertension management, thereby boosting the demand for fixed-dose combinations in the market.
Proliferation of Generic Drugs and Cost-Effectiveness: Following patent expirations, generic formulations of losartan have become widely accessible and economical. This trend is broadening treatment availability in developing areas and enhancing overall market penetration, particularly within public health initiatives.
Impact of Covid-19 on the Losartan Market
The COVID-19 pandemic significantly impacted the losartan market in various ways. Initially, global supply chain disruptions led to shortages and delays in the production and distribution of losartan due to lockdowns and restrictions, especially affecting key manufacturing hubs. This caused temporary supply gaps and challenged the availability of the medication. However, the pandemic also highlighted the importance of cardiovascular health, as individuals with pre-existing conditions such as hypertension were at a higher risk of severe COVID-19 complications. This increased awareness drove a higher demand for antihypertensive medications like losartan. Healthcare systems worldwide prioritized the management of chronic diseases, including hypertension, during the pandemic. This focus helped sustain the demand for losartan despite the supply chain challenges. Additionally, efforts were made to ensure that patients with chronic conditions continued to receive their medications without interruption. The heightened focus on cardiovascular health and the continuous need for effective hypertension management somewhat offset the adverse effects of the initial supply disruptions, maintaining a steady demand for losartan throughout the pandemic.
We have various report editions of Losartan Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Impact of Tariff Trumph on Pharmaceuticals Industry
The April 2025 “Liberation Day Tariffs” (10–46%) have disrupted global pharmaceutical trade, raising costs for APIs, packaging, and machinery from China and India. Generic drug makers, biopharma, vaccines, and CMOs face higher expenses, supply chain delays, and regulatory hurdles, while EU retaliation has further strained U.S. exports. Clinical trials are also delayed due to tariffs on drugs and kits. In this landscape, market research is vital, providing real-time data on pricing, suppliers, and tariff impacts to help companies optimize supply chains, find alternative hubs, and maintain competitiveness.
Losartan Market Insights Video
Competitive Landscape of the Losartan Market
In the Losartan market's competitive landscape, numerous key competitors are driving innovation and growth. Market rivalry is encouraging technological and design innovations to create Losartans that fulfil both consumer's wants and sustainability goals, keeping the market dynamic and competitive.
In June 2023, Merck completed the acquisition of Prometheus Biosciences, Inc. for an estimated $10.8 billion. This acquisition has significantly improved Merck's immunology pipeline by incorporating Prometheus' leading candidate, PRA-023 (MK-7240), a monoclonal antibody that is intended to treat ulcerative colitis, Crohn's disease, and other autoimmune conditions. This acquisition enhances Merck's research capabilities and fortifies its immunology position. Merck's 2023 GAAP and non-GAAP results will be significantly impacted by a charge of approximately $10.3 billion due to the deal. This acquisition is consistent with Merck's objective to enhance the treatment of immune-mediated diseases and provide patients with value. (Source: https://www.merck.com/news/merck-completes-acquisition-of-prometheus-biosciences-inc/) In June 2023, Deciding to acquire Chinook Therapeutics, a clinical-stage biopharmaceutical company, for a maximum of USD 3.5 billion, Novartis disclosed an agreement. This agreement comprises an initial payment of USD 3.2 billion and a contingent value right of up to USD 300 million. Chinook is a company that specializes in the development of treatments for IgA nephropathy (IgAN). It is currently in the third phase of development with two late-stage assets: atrasentan and zigakibart. The acquisition is consistent with Novartis' strategy to improve its renal portfolio and address unmet needs in the treatment of severe chronic kidney diseases. It is anticipated that the closure of the transaction will occur in the latter half of 2023. (Source: https://www.novartis.com/news/media-releases/novartis-bolsters-innovative-medicines-strategy-and-renal-pipeline-agreement-acquire-chinook-therapeutics-usd-32bn-upfront-usd-40-share) In June 2024, Dr. Reddy's Laboratories has announced its intention to acquire Haleon's global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy (NRT) category, with the exception of the United States. The acquisition encompasses the global NRT brand Nicotinell, as well as its local market-leading brands Nicabate, Habitrol, and Thrive. Dr. Reddy's objective is to strengthen its position in the consumer healthcare sector and to expand its over-the-counter (OTC) business through the acquisition, which is valued at GBP 500 million. Regulatory approvals are anticipated to be obtained prior to the transaction's completion in early Q4 2024. (Source: https://www.drreddys.com/cms/cms/sites/default/files/2024-06/Press%20release%20-%20Dr.%20Reddy%27s%20to%20acquire%20Nicotinell%20consumer%20healthcare.pdf)
Top Companies Market Share in Losartan Industry: (In no particular order of Rank)
| Companies | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Merck & Co. | xxxx | xxxx | xxxx | xxxx |
| Inc. | xxxx | xxxx | xxxx | xxxx |
| Pfizer Inc. | xxxx | xxxx | xxxx | xxxx |
| Teva Pharmaceutical Industries Ltd. | xxxx | xxxx | xxxx | xxxx |
| Dr. Reddy’s Laboratories Ltd. | xxxx | xxxx | xxxx | xxxx |
| Sun Pharmaceutical Industries Limited | xxxx | xxxx | xxxx | xxxx |
| Aurobindo Pharma Ltd | xxxx | xxxx | xxxx | xxxx |
| Torrent Pharmaceuticals Limited | xxxx | xxxx | xxxx | xxxx |
| Lupin Limited | xxxx | xxxx | xxxx | xxxx |
*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)
Request Any Company Profile for Preview Purpose OR Data Validation!
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Regional Analysis of the Losartan Market
Which Region Dominates the Losartan Market in 2024?
According to Cognitive Market Research, North America currently dominates the Losartans market, and the region is expected to have significant growth during the projected period. Hypertension is a prevalent health concern in the region, which has a sizable elderly population. The demand for these medications is robust due to the increased awareness of cardiovascular health and the availability of healthcare services.
Which Region is Expanding at the Fastest CAGR?
Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The Losartan Potassium API market is anticipated to experience significant growth in the Asia Pacific region as a result of the region's large population and the increasing prevalence of cardiovascular disorders and high blood pressure.
The current report Scope analyzes Losartan Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
- Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
- Africa (East Africa, West Africa, North Africa, South Africa)
Losartan Market Share (%) by Region (2022-2034)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
North America Losartan Market Analysis
According to Cognitive Market Research, the global Losartan market size was estimated at USD 1625.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 650.20 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031.
- According to Cognitive Market Research, the US had a major share in the Losartan market with a market size of USD 513.01 million in 2024 and is anticipated to grow at a CAGR of 2.5% during the projected period. The U.S. market's Increasing incidence of cardiovascular diseases and hypertension.
- The Canada Losartan market had a market share of USD 78.02 million in 2024 and is anticipated to grow at a CAGR of 3.5% during the projected period. Canada’s Increasing geriatric population and hypertension.
- The Mexico Losartan market is anticipated to see growth at a CAGR of 3.2% during the projected period, with a market size of USD 59.17 million in 2024.
Europe Losartan Market Analysis
According to Cognitive Market Research, the global Losartan market size was estimated at USD 1625.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 487.65 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.0% from 2024 to 2031.
- The United Kingdom Losartan market had a market share of USD 81.93 million in 2024 and is anticipated to grow at a CAGR of 3.8% during the projected period. In the UK, Losartan sales see an upswing due to the Increasing demand for hypertension treatments.
- The France Losartan market is anticipated to see growth at a CAGR of 2.2% during the projected period, with a market size of USD 44.86 million in 2024.
- According to Cognitive Market Research, the German Losartan market size was valued at USD 96.55 million in 2024 and is anticipated to grow at a CAGR of 3.2% during the projected period. In Germany, Losartan surged due to the significant healthcare infrastructure and an aging population.
- The Italy Losartan market is anticipated to see growth at a CAGR of 2.4% during the projected period, with a market size of USD 41.94 million in 2024.
- The Russia Losartan market is anticipated to see growth at a CAGR of 2.0% during the projected period, with a market size of USD 75.59 million in 2024.
- The Spain Losartan market is anticipated to see growth at a CAGR of 2.1% during the projected period with a market size of USD 39.99 million in 2024
- The Luxembourg Losartan market is anticipated to see growth at a CAGR of 3.1% during the projected period, with a market size of USD 15.12 million in 2024.
- The Portugal Losartan market is anticipated to see growth at a CAGR of 2.8% during the projected period, with a market size of USD 10.24 million in 2024.
- The Greece Losartan market is anticipated to see growth at a CAGR of 3.3% during the projected period, with a market size of USD 5.85 million in 2024.
- The Rest of Europe's Losartan market is anticipated to see growth at a CAGR of 1.7% during the projected period, with a market size of USD 75.59 million in 2024.
Asia Pacific Losartan Market Analysis
According to Cognitive Market Research, the global Losartan market size was estimated at USD 1625.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 373.87 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
- According to Cognitive Market Research, the China Losartan market size was valued at USD 168.24 million in 2024 and is anticipated to grow at a CAGR of 6.0% during the projected period. Losartan surged in China due to raising awareness and improving the treatment of hypertension.
- The Japan Losartan market is anticipated to see growth at a CAGR of 5.0% during the projected period, with a market size of USD 51.59 million in 2024.
- The India Losartan market had a market share of USD 44.86 million in 2024 and is anticipated to grow at a CAGR of 8.3% during the projected period. India's increasing prevalence of hypertension and the expansion of healthcare infrastructure.
- The South Korean Losartan market is anticipated to see growth at a CAGR of 5.6% during the projected period, with a market size of USD 37.39 million in 2024.
- The Australian Losartan market is anticipated to see growth at a CAGR of 6.2% during the projected period, with a market size of USD 19.44 million in 2024.
- The South East Asia Losartan market is anticipated to see growth at a CAGR of 7.5% during the projected period, with a market size of USD 25.80 million in 2024.
- The Rest of Asia Pacific Losartan market is anticipated to see growth at a CAGR of 6.3% during the projected period, with a market size of USD 26.54 million in 2024.
South America Losartan Market Analysis
According to Cognitive Market Research, the global Losartan market size was estimated at USD 1625.5 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 81.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031.
- According to Cognitive Market Research, the Brazil Losartan market size was valued at USD 34.79 million in 2024 and is anticipated to grow at a CAGR of 4.5% during the projected period. Losartan flourished in Brazil due to increasing incidence of cardiovascular diseases and hypertension.
- Argentina's Losartan market had a market share of USD 13.65 million in 2024 and is anticipated to grow at a CAGR of 4.8% during the projected period. Argentina's Increasing geriatric population and an increased prevalence of hypertension.
- Colombia Losartan market is anticipated to see growth at a CAGR of 3.7% during the projected period, with a market size of USD 7.23 million in 2024.
- Peru Losartan market is anticipated to see growth at a CAGR of 4.1% during the projected period, with a market size of USD 6.66 million in 2024.
- Chile Losartan market is anticipated to see growth at a CAGR of 4.2% during the projected period, with a market size of USD 5.85 million in 2024.
- The Rest of Latin America's Losartan market is anticipated to see growth at a CAGR of 3.0% during the projected period, with a market size of USD 13.09 million in 2024.
Middle East Losartan Market Analysis
According to Cognitive Market Research, the global Losartan market size was estimated at USD 1625.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 32.51 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031..
- The GCC Countries Losartan market is anticipated to see growth at a CAGR of 5.0% during the projected period, with a market size of USD 13.91 million in 2024. Losartan sales flourish due to the Increasing awareness and education regarding hypertension treatments.
- The Egypt Losartan market is anticipated to see growth at a CAGR of 4.5% during the projected period, with a market size of USD 3.41 million in 2024.
- The South Africa Losartan market is anticipated to see growth at a CAGR of 5.2% during the projected period, with a market size of USD 5.14 million in 2024. Losartan sales flourished in South Africa due to Enhanced healthcare infrastructure and an increase in the demand for hypertension medication.
- The Turkey Losartan market is anticipated to see growth at a CAGR of 3.7% during the projected period, with a market size of USD 2.80 million in 2024.
- The Nigeria Losartan market is anticipated to see growth at a CAGR of 3.3% during the projected period, with a market size of USD 3.41 million in 2024.
- The Rest of the MEA Losartan market is anticipated to see growth at a CAGR of 3.2% during the projected period, with a market size of USD 3.84 million in 2024.
Author's Conclusion
Conclusion
- The global Losartan market will expand significantly by 4.50% CAGR between 2024 and 2031.
- Tablet is expected to dominate the Losartan Market over the forecast period owing to the fact that it is simple to administer and guarantee patient compliance.
- The In-house Manufacturing segment has the biggest market share as a result of the preference of major market participants for complete control over the quality and quantity of the products.
Author's Detail
Supriya YadavResearch Analyst
LinkedIn | Profile | Book Appointment
Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.
Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.
As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.
My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.
I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.
Frequently Asked Questions (FAQs)
Reviews
Losartan Market Segmentation Analysis from 2022 till 2034
Global Losartan Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Losartan Industry growth. Losartan market has been segmented with the help of its Dosage Form, Application Distribution Channel, and others. Losartan market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Losartan Market Dosage Form Segment Analysis
According to Cognitive Market Research, tablets are likely to dominate the Losartan Market over the forecast period owing to the fact that it is simple to administer and guarantee patient compliance.
Powder is the fastest-growing segment in the Losartan Market due to the fact that it may be administered in a variety of dose forms and can be combined with other therapeutic agents or solutions.
Losartan Market Share (%) by Dosage Form in 2022-2034
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Losartan Industry. Request a Free Sample PDF!
Losartan Market Application Segment Analysis
According to Cognitive Market Research, the Hypertension segment holds the largest share of the market. The Losartan market is dominated by hypertension, which is the primary condition for which Losartan is prescribed. An angiotensin II receptor blocker (ARB), losartan is a critical medication for the management of hypertension due to its ability to reduce blood pressure effectively. The demand for Losartan is driven by the high prevalence of hypertension worldwide, resulting in its dominant position in the market.
In the Losartan Market, Diabetic Nephropathy has been expanding at a rapid pace. The Losartan market's fastest-growing category is Diabetic Nephropathy, which is associated with the rising prevalence of diabetes and the risk of renal complications. Losartan is prescribed to safeguard renal function in diabetic patients, leading to an increase in demand for this application among healthcare providers who are seeking effective treatments to prevent and manage kidney harm in this demographic.
Losartan Market Share (%) by Application in 2022-2034
2022
2026
2034
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Distribution Channel Segmentation Analysis from 2022 till 2034: Contract Manufacturing, In-house Manufacturing, Others
Losartan Market Distribution Channel Segment Analysis
According to Cognitive Market Research, The In-house Manufacturing segment holds the largest market share as a result of the preference of major market participants for complete control over the quality and quantity of the products.
In the Losartan market, the rapidly growing sector is the Contract Manufacturing category. The growth in this category is due to the growing demand for outsourcing manufacturing operations to specialized organizations.
- Contract Manufacturing
- In-house Manufacturing
- Others
Losartan Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Dosage Form | Tablet, Powder, Suspension |
| Application | Hypertension, Stroke, Diabetic Nephropathy, Others |
| Distribution Channel | Contract Manufacturing, In-house Manufacturing, Others |
| List of Competitors | Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd, Torrent Pharmaceuticals Limited, Lupin Limited |
Chapter 1 2026 Geopolitical Outlook - Losartan Market Detailed Analysis
-
1.1 Global Power Realignment & Strategic Alliances
-
1.2 Geopolitical Risk Landscape & Conflict Hotspots
-
1.3 International Trade Relations & Market Access Environment
-
1.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
-
1.5 Supply Chain Resilience, Localization & Resource Nationalism
-
1.6 Technology Sovereignty & Digital Geopolitics
-
1.7 Strategic Implications for Investment, Growth & Market Entry
This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
-
2.1 Competitive Landscape Disruption & Strategic Shifts
-
2.2 AI-Driven Transformation of Industry Value Chain
-
2.3 Evolution of Business Models & Revenue Streams
-
2.4 Operational Efficiency & Cost Structure Transformation
-
2.5 Product, Service & Innovation Acceleration
-
2.6 Customer Behavior & Demand Evolution
-
2.7 Future Outlook: AI-Led Market Evolution & Strategic Implications
This chapter will help you gain GLOBAL Market Analysis of Losartan. Further deep in this chapter, you will be able to review Global Losartan Market Split by various segments and Geographical Split.
Chapter 3 Global Market Analysis
-
3.1 Global Losartan Revenue Market Size, Trend Analysis 2022 - 2034
-
3.2 Global Losartan Volume Market Sales, Trend Analysis 2022 - 2034
-
3.3 Global Losartan Market Size By Regions 2022 - 2034
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
3.3.1 Global Losartan Revenue Market Size By Region
-
3.3.2 Global Losartan Volume Market Sales By Region
-
-
3.4 Global Losartan Market Size By Dosage Form 2022 - 2034
-
3.4.1 Tablet Market Size
-
3.4.2 Powder Market Size
-
3.4.3 Suspension Market Size
-
-
3.5 Global Losartan Volume Market Sales By Dosage Form 2022 - 2034
-
3.5.1 Tablet Sales Volume
-
3.5.2 Powder Sales Volume
-
3.5.3 Suspension Sales Volume
-
-
3.6 Global Losartan Market Size By Application 2022 - 2034
-
3.6.1 Hypertension Market Size
-
3.6.2 Stroke Market Size
-
3.6.3 Diabetic Nephropathy Market Size
-
3.6.4 Others Market Size
-
-
3.7 Global Losartan Volume Market Sales By Application 2022 - 2034
-
3.7.1 Hypertension Sales Volume
-
3.7.2 Stroke Sales Volume
-
3.7.3 Diabetic Nephropathy Sales Volume
-
3.7.4 Others Sales Volume
-
-
3.8 Global Losartan Market Size By Distribution Channel 2022 - 2034
-
3.8.1 Contract Manufacturing Market Size
-
3.8.2 In-house Manufacturing Market Size
-
3.8.3 Others Market Size
-
-
3.9 Global Losartan Volume Market Sales By Distribution Channel 2022 - 2034
-
3.9.1 Contract Manufacturing Sales Volume
-
3.9.2 In-house Manufacturing Sales Volume
-
3.9.3 Others Sales Volume
-
-
3.10 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
3.11 Executive Summary Global Market (2021 vs 2025 vs 2033)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
3.11.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
-
3.11.2 Regional Volume Market Summary 2021 vs 2025 vs 2033
-
3.11.3 Global Market Revenue Split By Dosage Form
-
3.11.4 Global Volume Market Split By Dosage Form
-
3.11.5 Global Market Revenue Split By Application
-
3.11.6 Global Volume Market Split By Application
-
3.11.7 Global Market Revenue Split By Distribution Channel
-
3.11.8 Global Volume Market Split By Distribution Channel
-
3.11.9 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
This chapter will help you gain North America Market Analysis of Losartan. Further deep in this chapter, you will be able to review North America Losartan Market Split by various segments and Country Split.
Chapter 4 North America Market Analysis
-
4.1 North America Losartan Market Outlook
-
4.1.1 North America Losartan Market Size 2022 - 2034
-
4.1.2 North America Losartan Volume Market Sales 2022 - 2034
-
4.1.3 North America Losartan Market Size By Country 2022 - 2034
-
4.1.4 North America Losartan Volume Market Sales By Country 2022 - 2034
-
4.1.5 North America Losartan Market Size by Dosage Form 2022 - 2034
-
4.1.5.1 North America Tablet Market Size
-
4.1.5.2 North America Powder Market Size
-
4.1.5.3 North America Suspension Market Size
-
-
4.1.6 North America Losartan Volume Market Sales by Dosage Form 2022 - 2034
-
4.1.6.1 North America Tablet Sales Volume
-
4.1.6.2 North America Powder Sales Volume
-
4.1.6.3 North America Suspension Sales Volume
-
-
4.1.7 North America Losartan Market Size by Application 2022 - 2034
-
4.1.7.1 North America Hypertension Market Size
-
4.1.7.2 North America Stroke Market Size
-
4.1.7.3 North America Diabetic Nephropathy Market Size
-
4.1.7.4 North America Others Market Size
-
-
4.1.8 North America Losartan Volume Market Sales by Application 2022 - 2034
-
4.1.8.1 North America Hypertension Sales Volume
-
4.1.8.2 North America Stroke Sales Volume
-
4.1.8.3 North America Diabetic Nephropathy Sales Volume
-
4.1.8.4 North America Others Sales Volume
-
-
4.1.9 North America Losartan Market Size by Distribution Channel 2022 - 2034
-
4.1.9.1 North America Contract Manufacturing Market Size
-
4.1.9.2 North America In-house Manufacturing Market Size
-
4.1.9.3 North America Others Market Size
-
-
4.1.10 North America Losartan Volume Market Sales by Distribution Channel 2022 - 2034
-
4.1.10.1 North America Contract Manufacturing Sales Volume
-
4.1.10.2 North America In-house Manufacturing Sales Volume
-
4.1.10.3 North America Others Sales Volume
-
-
This chapter will help you gain Europe Market Analysis of Losartan. Further deep in this chapter, you will be able to review Europe Losartan Market Split by various segments and Country Split.
Chapter 5 Europe Market Analysis
-
5.1 Europe Losartan Market Outlook
-
5.1.1 Europe Losartan Market Size 2022 - 2034
-
5.1.2 Europe Losartan Volume Market Sales 2022 - 2034
-
5.1.3 Europe Losartan Market Size By Country 2022 - 2034
-
5.1.4 Europe Losartan Volume Market Sales By Country 2022 - 2034
-
5.1.5 Europe Losartan Market Size by Dosage Form 2022 - 2034
-
5.1.5.1 Europe Tablet Market Size
-
5.1.5.2 Europe Powder Market Size
-
5.1.5.3 Europe Suspension Market Size
-
-
5.1.6 Europe Losartan Volume Market Sales by Dosage Form 2022 - 2034
-
5.1.6.1 Europe Tablet Sales Volume
-
5.1.6.2 Europe Powder Sales Volume
-
5.1.6.3 Europe Suspension Sales Volume
-
-
5.1.7 Europe Losartan Market Size by Application 2022 - 2034
-
5.1.7.1 Europe Hypertension Market Size
-
5.1.7.2 Europe Stroke Market Size
-
5.1.7.3 Europe Diabetic Nephropathy Market Size
-
5.1.7.4 Europe Others Market Size
-
-
5.1.8 Europe Losartan Volume Market Sales by Application 2022 - 2034
-
5.1.8.1 Europe Hypertension Sales Volume
-
5.1.8.2 Europe Stroke Sales Volume
-
5.1.8.3 Europe Diabetic Nephropathy Sales Volume
-
5.1.8.4 Europe Others Sales Volume
-
-
5.1.9 Europe Losartan Market Size by Distribution Channel 2022 - 2034
-
5.1.9.1 Europe Contract Manufacturing Market Size
-
5.1.9.2 Europe In-house Manufacturing Market Size
-
5.1.9.3 Europe Others Market Size
-
-
5.1.10 Europe Losartan Volume Market Sales by Distribution Channel 2022 - 2034
-
5.1.10.1 Europe Contract Manufacturing Sales Volume
-
5.1.10.2 Europe In-house Manufacturing Sales Volume
-
5.1.10.3 Europe Others Sales Volume
-
-
This chapter will help you gain Asia Pacific Market Analysis of Losartan. Further deep in this chapter, you will be able to review Asia Pacific Losartan Market Split by various segments and Country Split.
Chapter 6 Asia Pacific Market Analysis
-
6.1 Asia Pacific Losartan Market Outlook
-
6.1.1 Asia Pacific Losartan Market Size 2022 - 2034
-
6.1.2 Asia Pacific Losartan Volume Market Sales 2022 - 2034
-
6.1.3 Asia Pacific Losartan Market Size By Country 2022 - 2034
-
6.1.4 Asia Pacific Losartan Volume Market Sales By Country 2022 - 2034
-
6.1.5 Asia Pacific Losartan Market Size by Dosage Form 2022 - 2034
-
6.1.5.1 Asia Pacific Tablet Market Size
-
6.1.5.2 Asia Pacific Powder Market Size
-
6.1.5.3 Asia Pacific Suspension Market Size
-
-
6.1.6 Asia Pacific Losartan Volume Market Sales by Dosage Form 2022 - 2034
-
6.1.6.1 Asia Pacific Tablet Sales Volume
-
6.1.6.2 Asia Pacific Powder Sales Volume
-
6.1.6.3 Asia Pacific Suspension Sales Volume
-
-
6.1.7 Asia Pacific Losartan Market Size by Application 2022 - 2034
-
6.1.7.1 Asia Pacific Hypertension Market Size
-
6.1.7.2 Asia Pacific Stroke Market Size
-
6.1.7.3 Asia Pacific Diabetic Nephropathy Market Size
-
6.1.7.4 Asia Pacific Others Market Size
-
-
6.1.8 Asia Pacific Losartan Volume Market Sales by Application 2022 - 2034
-
6.1.8.1 Asia Pacific Hypertension Sales Volume
-
6.1.8.2 Asia Pacific Stroke Sales Volume
-
6.1.8.3 Asia Pacific Diabetic Nephropathy Sales Volume
-
6.1.8.4 Asia Pacific Others Sales Volume
-
-
6.1.9 Asia Pacific Losartan Market Size by Distribution Channel 2022 - 2034
-
6.1.9.1 Asia Pacific Contract Manufacturing Market Size
-
6.1.9.2 Asia Pacific In-house Manufacturing Market Size
-
6.1.9.3 Asia Pacific Others Market Size
-
-
6.1.10 Asia Pacific Losartan Volume Market Sales by Distribution Channel 2022 - 2034
-
6.1.10.1 Asia Pacific Contract Manufacturing Sales Volume
-
6.1.10.2 Asia Pacific In-house Manufacturing Sales Volume
-
6.1.10.3 Asia Pacific Others Sales Volume
-
-
This chapter will help you gain South America Market Analysis of Losartan. Further deep in this chapter, you will be able to review South America Losartan Market Split by various segments and Country Split.
Chapter 7 South America Market Analysis
-
7.1 South America Losartan Market Outlook
-
7.1.1 South America Losartan Market Size 2022 - 2034
-
7.1.2 South America Losartan Volume Market Sales 2022 - 2034
-
7.1.3 South America Losartan Market Size By Country 2022 - 2034
-
7.1.4 South America Losartan Volume Market Sales By Country 2022 - 2034
-
7.1.5 South America Losartan Market Size by Dosage Form 2022 - 2034
-
7.1.5.1 South America Tablet Market Size
-
7.1.5.2 South America Powder Market Size
-
7.1.5.3 South America Suspension Market Size
-
-
7.1.6 South America Losartan Volume Market Sales by Dosage Form 2022 - 2034
-
7.1.6.1 South America Tablet Sales Volume
-
7.1.6.2 South America Powder Sales Volume
-
7.1.6.3 South America Suspension Sales Volume
-
-
7.1.7 South America Losartan Market Size by Application 2022 - 2034
-
7.1.7.1 South America Hypertension Market Size
-
7.1.7.2 South America Stroke Market Size
-
7.1.7.3 South America Diabetic Nephropathy Market Size
-
7.1.7.4 South America Others Market Size
-
-
7.1.8 South America Losartan Volume Market Sales by Application 2022 - 2034
-
7.1.8.1 South America Hypertension Sales Volume
-
7.1.8.2 South America Stroke Sales Volume
-
7.1.8.3 South America Diabetic Nephropathy Sales Volume
-
7.1.8.4 South America Others Sales Volume
-
-
7.1.9 South America Losartan Market Size by Distribution Channel 2022 - 2034
-
7.1.9.1 South America Contract Manufacturing Market Size
-
7.1.9.2 South America In-house Manufacturing Market Size
-
7.1.9.3 South America Others Market Size
-
-
7.1.10 South America Losartan Volume Market Sales by Distribution Channel 2022 - 2034
-
7.1.10.1 South America Contract Manufacturing Sales Volume
-
7.1.10.2 South America In-house Manufacturing Sales Volume
-
7.1.10.3 South America Others Sales Volume
-
-
This chapter will help you gain Middle East Market Analysis of Losartan. Further deep in this chapter, you will be able to review Middle East Losartan Market Split by various segments and Country Split.
Chapter 8 Middle East Market Analysis
-
8.1 Middle East Losartan Market Outlook
-
8.1.1 Middle East Losartan Market Size 2022 - 2034
-
8.1.2 Middle East Losartan Volume Market Sales 2022 - 2034
-
8.1.3 Middle East Losartan Market Size By Country 2022 - 2034
-
8.1.4 Middle East Losartan Volume Market Sales By Country 2022 - 2034
-
8.1.5 Middle East Losartan Market Size by Dosage Form 2022 - 2034
-
8.1.5.1 Middle East Tablet Market Size
-
8.1.5.2 Middle East Powder Market Size
-
8.1.5.3 Middle East Suspension Market Size
-
-
8.1.6 Middle East Losartan Volume Market Sales by Dosage Form 2022 - 2034
-
8.1.6.1 Middle East Tablet Sales Volume
-
8.1.6.2 Middle East Powder Sales Volume
-
8.1.6.3 Middle East Suspension Sales Volume
-
-
8.1.7 Middle East Losartan Market Size by Application 2022 - 2034
-
8.1.7.1 Middle East Hypertension Market Size
-
8.1.7.2 Middle East Stroke Market Size
-
8.1.7.3 Middle East Diabetic Nephropathy Market Size
-
8.1.7.4 Middle East Others Market Size
-
-
8.1.8 Middle East Losartan Volume Market Sales by Application 2022 - 2034
-
8.1.8.1 Middle East Hypertension Sales Volume
-
8.1.8.2 Middle East Stroke Sales Volume
-
8.1.8.3 Middle East Diabetic Nephropathy Sales Volume
-
8.1.8.4 Middle East Others Sales Volume
-
-
8.1.9 Middle East Losartan Market Size by Distribution Channel 2022 - 2034
-
8.1.9.1 Middle East Contract Manufacturing Market Size
-
8.1.9.2 Middle East In-house Manufacturing Market Size
-
8.1.9.3 Middle East Others Market Size
-
-
8.1.10 Middle East Losartan Volume Market Sales by Distribution Channel 2022 - 2034
-
8.1.10.1 Middle East Contract Manufacturing Sales Volume
-
8.1.10.2 Middle East In-house Manufacturing Sales Volume
-
8.1.10.3 Middle East Others Sales Volume
-
-
This chapter will help you gain Middle East Market Analysis of Losartan. Further deep in this chapter, you will be able to review Middle East Losartan Market Split by various segments and Country Split.
Chapter 9 Africa Market Analysis
-
9.1 Africa Losartan Market Outlook
-
9.1.1 Africa Losartan Market Size 2022 - 2034
-
9.1.2 Africa Losartan Volume Market Sales 2022 - 2034
-
9.1.3 Africa Losartan Market Size By Country 2022 - 2034
-
9.1.4 Africa Losartan Volume Market Sales By Country 2022 - 2034
-
9.1.5 Africa Losartan Market Size by Dosage Form 2022 - 2034
-
9.1.5.1 Africa Tablet Market Size
-
9.1.5.2 Africa Powder Market Size
-
9.1.5.3 Africa Suspension Market Size
-
-
9.1.6 Africa Losartan Volume Market Sales by Dosage Form 2022 - 2034
-
9.1.6.1 Africa Tablet Sales Volume
-
9.1.6.2 Africa Powder Sales Volume
-
9.1.6.3 Africa Suspension Sales Volume
-
-
9.1.7 Africa Losartan Market Size by Application 2022 - 2034
-
9.1.7.1 Africa Hypertension Market Size
-
9.1.7.2 Africa Stroke Market Size
-
9.1.7.3 Africa Diabetic Nephropathy Market Size
-
9.1.7.4 Africa Others Market Size
-
-
9.1.8 Africa Losartan Volume Market Sales by Application 2022 - 2034
-
9.1.8.1 Africa Hypertension Sales Volume
-
9.1.8.2 Africa Stroke Sales Volume
-
9.1.8.3 Africa Diabetic Nephropathy Sales Volume
-
9.1.8.4 Africa Others Sales Volume
-
-
9.1.9 Africa Losartan Market Size by Distribution Channel 2022 - 2034
-
9.1.9.1 Africa Contract Manufacturing Market Size
-
9.1.9.2 Africa In-house Manufacturing Market Size
-
9.1.9.3 Africa Others Market Size
-
-
9.1.10 Africa Losartan Volume Market Sales by Distribution Channel 2022 - 2034
-
9.1.10.1 Africa Contract Manufacturing Sales Volume
-
9.1.10.2 Africa In-house Manufacturing Sales Volume
-
9.1.10.3 Africa Others Sales Volume
-
-
This chapter provides an in-depth analysis of the market share among key competitors of Losartan. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
-
10.1 Top Competitors Analysis
-
10.1.1 Global Losartan Market Revenue and Share by Key Players
(Subject to Data Availability (Private Players))
-
10.1.2 Global Losartan Market Volume and Share by Key Players
-
10.1.3 Top Players Ranking 2024
-
10.1.4 New Product Launch Analysis
-
10.1.5 Industry Mergers and Acquisition Analysis
-
-
10.2 Company Profile (Data Subject to Availability) Sample Format
-
10.2.1 Merck & Co.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
10.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
10.2.1.2 Business Overview
-
10.2.1.3 Financials (Subject to data availability)
-
10.2.1.4 R&D Investment (Subject to data availability)
-
10.2.1.5 Product Types Specification
-
10.2.1.6 Business Strategy
-
10.2.1.7 Recent Developments
-
10.2.1.8 Management Change
-
10.2.1.9 S.W.O.T Analysis
-
-
10.2.2 Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
10.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
10.2.2.2 Business Overview
-
10.2.2.3 Financials (Subject to data availability)
-
10.2.2.4 R&D Investment (Subject to data availability)
-
10.2.2.5 Product Types Specification
-
10.2.2.6 Business Strategy
-
10.2.2.7 Recent Developments
-
10.2.2.8 Management Change
-
10.2.2.9 S.W.O.T Analysis
-
-
10.2.3 Pfizer Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
10.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
10.2.3.2 Business Overview
-
10.2.3.3 Financials (Subject to data availability)
-
10.2.3.4 R&D Investment (Subject to data availability)
-
10.2.3.5 Product Types Specification
-
10.2.3.6 Business Strategy
-
10.2.3.7 Recent Developments
-
10.2.3.8 Management Change
-
10.2.3.9 S.W.O.T Analysis
-
-
10.2.4 Teva Pharmaceutical Industries Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
10.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
10.2.4.2 Business Overview
-
10.2.4.3 Financials (Subject to data availability)
-
10.2.4.4 R&D Investment (Subject to data availability)
-
10.2.4.5 Product Types Specification
-
10.2.4.6 Business Strategy
-
10.2.4.7 Recent Developments
-
10.2.4.8 Management Change
-
10.2.4.9 S.W.O.T Analysis
-
-
10.2.5 Dr. Reddy’s Laboratories Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
10.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
10.2.5.2 Business Overview
-
10.2.5.3 Financials (Subject to data availability)
-
10.2.5.4 R&D Investment (Subject to data availability)
-
10.2.5.5 Product Types Specification
-
10.2.5.6 Business Strategy
-
10.2.5.7 Recent Developments
-
10.2.5.8 Management Change
-
10.2.5.9 S.W.O.T Analysis
-
-
10.2.6 Sun Pharmaceutical Industries Limited
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
10.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
10.2.6.2 Business Overview
-
10.2.6.3 Financials (Subject to data availability)
-
10.2.6.4 R&D Investment (Subject to data availability)
-
10.2.6.5 Product Types Specification
-
10.2.6.6 Business Strategy
-
10.2.6.7 Recent Developments
-
10.2.6.8 Management Change
-
10.2.6.9 S.W.O.T Analysis
-
-
10.2.7 Aurobindo Pharma Ltd
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
10.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
10.2.7.2 Business Overview
-
10.2.7.3 Financials (Subject to data availability)
-
10.2.7.4 R&D Investment (Subject to data availability)
-
10.2.7.5 Product Types Specification
-
10.2.7.6 Business Strategy
-
10.2.7.7 Recent Developments
-
10.2.7.8 Management Change
-
10.2.7.9 S.W.O.T Analysis
-
-
10.2.8 Torrent Pharmaceuticals Limited
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
10.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
10.2.8.2 Business Overview
-
10.2.8.3 Financials (Subject to data availability)
-
10.2.8.4 R&D Investment (Subject to data availability)
-
10.2.8.5 Product Types Specification
-
10.2.8.6 Business Strategy
-
10.2.8.7 Recent Developments
-
10.2.8.8 Management Change
-
10.2.8.9 S.W.O.T Analysis
-
-
10.2.9 Lupin Limited
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
10.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
10.2.9.2 Business Overview
-
10.2.9.3 Financials (Subject to data availability)
-
10.2.9.4 R&D Investment (Subject to data availability)
-
10.2.9.5 Product Types Specification
-
10.2.9.6 Business Strategy
-
10.2.9.7 Recent Developments
-
10.2.9.8 Management Change
-
10.2.9.9 S.W.O.T Analysis
-
-
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 11 Qualitative Analysis (Subject to Data Availability)
-
11.1 Market Drivers
-
11.2 Market Restraints
-
11.3 Market Trends
-
11.4 Market Opportunity
-
11.5 Technological Road Map (Subject to Data Availability)
-
11.6 Product Life Cycle (Subject to Data Availability)
-
11.7 Customer and Buyer Behavior Analysis
-
11.7.1 Consumer Demographics and Target Audience Assessment
-
11.7.2 Consumer Purchase Behavior and Demand Assessment
-
11.7.3 Consumer Pricing Dynamics and Affordability Assessment
-
11.7.4 Digital Consumer Engagement and Online Adoption Analysis
-
11.7.5 Future Consumption Trends and Demand Evolution Analysis
-
11.7.6 Enterprise Procurement & Purchasing Behavior Analysis
-
11.7.7 Buyer Decision-Making & Purchase Influence Assessment
-
11.7.8 Customer Expectations & Service Experience Evaluation
-
11.7.9 Vendor Selection & Supplier Preference Analysis
-
11.7.10 Customer Retention & Loyalty Strategy Assessment
-
11.7.11 Pricing Sensitivity & Value Perception Analysis
-
11.7.12 Customer Segmentation & Demand Pattern Analysis
-
11.7.13 Relationship Management & Strategic Partnership Trends
-
-
11.8 Market Attractiveness Analysis
-
11.9 PESTEL Analysis
-
11.9.1 Political Factors
-
11.9.2 Economic Factors
-
11.9.3 Social Factors
-
11.9.4 Technological Factors
-
11.9.5 Legal Factors
-
11.9.6 Environmental Factors
-
-
11.10 Industrial Chain Analysis (Subject to Data Availability)
-
11.10.1 Industry Chain Analysis
-
11.10.2 Manufacturing Cost Analysis
-
11.10.3 Supply Side Analysis
-
11.10.3.1 Raw Material Analysis
-
11.10.3.2 Raw Material Procurement Analysis
-
11.10.3.3 Raw Material Price Trend Analysis
-
-
-
11.11 Porter’s Five Forces Analysis
-
11.11.1 Bargaining Power of Suppliers
-
11.11.2 Bargaining Power of Buyers
-
11.11.3 Threat of New Entrants
-
11.11.4 Threat of Substitutes
-
11.11.5 Degree of Competition
-
-
11.12 Patent Analysis (Subject to Data Availability)
-
11.13 ESG Analysis
Segmentation Dosage Form Analysis 2019 -2031, will provide market size split by Dosage Form. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Dosage Form Analysis 2022 - 2034
-
12.1 Tablet
-
12.1.1 Global Losartan Revenue Market Size and Share by Tablet 2022 - 2034
-
12.1.2 Global Losartan Volume Market Sales by Tablet 2022 - 2034
-
-
12.2 Powder
-
12.2.1 Global Losartan Revenue Market Size and Share by Powder 2022 - 2034
-
12.2.2 Global Losartan Volume Market Sales by Powder 2022 - 2034
-
-
12.3 Suspension
-
12.3.1 Global Losartan Revenue Market Size and Share by Suspension 2022 - 2034
-
12.3.2 Global Losartan Volume Market Sales by Suspension 2022 - 2034
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Application Analysis 2022 - 2034
-
13.1 Hypertension
-
13.1.1 Global Losartan Revenue Market Size and Share by Hypertension 2022 - 2034
-
13.1.2 Global Losartan Volume Market Sales by Hypertension 2022 - 2034
-
-
13.2 Stroke
-
13.2.1 Global Losartan Revenue Market Size and Share by Stroke 2022 - 2034
-
13.2.2 Global Losartan Volume Market Sales by Stroke 2022 - 2034
-
-
13.3 Diabetic Nephropathy
-
13.3.1 Global Losartan Revenue Market Size and Share by Diabetic Nephropathy 2022 - 2034
-
13.3.2 Global Losartan Volume Market Sales by Diabetic Nephropathy 2022 - 2034
-
-
13.4 Others
-
13.4.1 Global Losartan Revenue Market Size and Share by Others 2022 - 2034
-
13.4.2 Global Losartan Volume Market Sales by Others 2022 - 2034
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by Distribution Channel Analysis 2022 - 2034
-
14.1 Contract Manufacturing
-
14.1.1 Global Losartan Revenue Market Size and Share by Contract Manufacturing 2022 - 2034
-
14.1.2 Global Losartan Volume Market Sales by Contract Manufacturing 2022 - 2034
-
-
14.2 In-house Manufacturing
-
14.2.1 Global Losartan Revenue Market Size and Share by In-house Manufacturing 2022 - 2034
-
14.2.2 Global Losartan Volume Market Sales by In-house Manufacturing 2022 - 2034
-
-
14.3 Others
-
14.3.1 Global Losartan Revenue Market Size and Share by Others 2022 - 2034
-
14.3.2 Global Losartan Volume Market Sales by Others 2022 - 2034
-
Chapter 15 Losartan Price Trend Analysis
-
15.1 Global Losartan Price Trend Analysis
-
15.2 Global Losartan Price Trend Analysis By Region
-
15.3 North America Losartan Price Trend Analysis
-
15.4 Europe Losartan Price Trend Analysis
-
15.5 Asia Pacific Losartan Price Trend Analysis
-
15.6 South America Losartan Price Trend Analysis
-
15.7 Middle East Losartan Price Trend Analysis
-
15.8 Africa Losartan Price Trend Analysis
-
15.9 Losartan Price Trend Analysis By Dosage Form
-
15.9.1 Global Losartan Price Trend Analysis By Dosage Form
-
Chapter 16 Losartan Import/Export Analysis
-
16.1 Global Losartan Market Import Data (2022-2025)
-
16.2 Global Losartan Market Export Data (2019-2023)
-
16.3 Global Losartan Market Import Data by Region (2019-2023)
-
16.4 Global Losartan Market Export Data by Region (2019-2023)
-
16.5 North America Losartan Market Import Data by Country (2019-2023)
-
16.6 North America Losartan Market Export Data by Country (2019-2023)
-
16.7 Europe Losartan Market Import Data by Country (2019-2023)
-
16.8 Europe Losartan Market Export Data by Country (2019-2023)
-
16.9 Asia Pacific Losartan Market Import Data by Country (2019-2023)
-
16.10 Asia Pacific Losartan Market Export Data by Country (2019-2023)
-
16.11 South America Losartan Market Import Data by Country (2019-2023)
-
16.12 South America Losartan Market Export Data by Country (2019-2023)
-
16.13 Middle East and Africa Losartan Market Import Data by Country (2019-2023)
-
16.14 Middle East and Africa Losartan Market Export Data by Country (2019-2023)
Chapter 17 Losartan Production Analysis
-
17.1 Global Losartan Market Production Data (2022-2025)
-
17.2 Global Losartan Market Production by Region (2022-2025)
-
17.3 North America Losartan Production Analysis (2022-2025)
-
17.4 Europe Losartan Production Analysis (2022-2025)
-
17.5 Asia Pacific Losartan Production Analysis (2022-2025)
-
17.6 South America Losartan Production Analysis (2022-2025)
-
17.7 Middle East Losartan Production Analysis (2022-2025)
-
17.8 Africa Losartan Production Analysis (2022-2025)
-
17.9 Losartan Market Production Analysis By Company
-
17.9.1 Global Losartan Market Production Analysis By Company
-
17.9.2 North America Losartan Market Production Analysis By Company
-
17.9.3 Europe Losartan Market Production Analysis By Company
-
17.9.4 Asia Pacific Losartan Market Production Analysis By Company
-
17.9.5 South America Losartan Market Production Analysis By Company
-
17.9.6 Middle East Losartan Market Production Analysis By Company
-
17.9.7 Africa Losartan Market Production Analysis By Company
-
Chapter 18 Gap Analysis
-
18.1 Company Gap Assessment Analysis
-
18.2 Product & Service Portfolio Gap Analysis
-
18.3 Demand-Supply Imbalance Analysis
-
18.4 Market Opportunity & Unmet Needs Analysis
-
18.5 Technology Adoption & Digital Transformation Gap Analysis
-
18.6 Operational Efficiency & Process Gap Analysis
-
18.7 Infrastructure & Capacity Gap Analysis
-
18.8 Geographic Coverage & Distribution Gap Analysis
-
18.9 Investment Opportunity & Funding Gap Analysis
-
18.10 Pricing Structure & Margin Gap Analysis
-
18.11 Innovation & R&D Capability Gap Analysis
-
18.12 Policy, Compliance & Regulatory Gap Analysis
-
18.13 Customer Experience & Expectation Gap Analysis
-
18.14 Future Growth Opportunity Gap Analysis
-
18.15 Market Accessibility & Penetration Gap Analysis
Chapter 19 Strategy Analysis
-
19.1 Strategic Commercialization & Pricing Assessment
Chapter 20 Profitability and Gross Margin Analysis
-
20.1 Gross Margin Overview and Industry Profitability Trends
-
20.2 Regional Gross Margin Performance Analysis
-
20.3 Supply Chain and Distribution Impact on Gross Margins
-
20.4 Pricing Strategy and Value-Added Margin Assessment
-
20.5 Key Factors Influencing Gross Margin Variability
-
20.6 Future Gross Margin Outlook and Profitability Trends
Chapter 21 TAM Analysis
-
21.1 Global Losartan Market TAM Analysis
-
21.2 North America Losartan Market TAM Analysis
-
21.3 Europe Losartan Market TAM Analysis
-
21.4 Asia Pacific Losartan Market TAM Analysis
-
21.5 South America Losartan Market TAM Analysis
-
21.6 Middle East Losartan Market TAM Analysis
-
21.7 Africa Losartan Market TAM Analysis
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Losartan market
Chapter 22 Research Findings
-
22.1 Key Takeaways
-
22.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
22.3 Assumptions and Acronyms
Chapter 23 Research Methodology and Sources
-
23.1 Primary Data Collection
-
23.1.1 Steps for Primary Data Collection
-
23.1.1.1 Identification of KOL
-
-
23.1.2 Backward Integration
-
23.1.3 Forward Integration
-
23.1.4 How Primary Research Help Us
-
23.1.5 Modes of Primary Research
-
-
23.2 Secondary Research
-
23.2.1 How Secondary Research Help Us
-
23.2.2 Sources of Secondary Research
-
-
23.3 Data Validation
-
23.3.1 Data Triangulation
-
23.3.2 Top Down & Bottom Up Approach
-
23.3.3 Cross check KOL Responses with Secondary Data
-
-
23.4 Data Representation
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Cognitive's Full Truth Proprietary Research Methodology Implemented by Supriya Yadav and Team
1 Data Gathering
-
1.1 Research Design & Problem Structuring
-
1.1.1 Identification of Research Objectives
-
1.1.2 Market, Region, and Timeframe Definition
-
1.1.3 Problem Decomposition & Hypothesis Development
-
1.1.4 Mapping Data Requirements & Analytical Framework
-
-
1.2 Data Architecture & Multi-Source Intelligence
-
1.2.1 Primary Research
-
1.2.1.1 Manufacturers, distributors, and traders
-
1.2.1.2 Procurement managers and industry buyers
-
1.2.1.3 Technology providers and innovators
-
1.2.1.4 Regulators and policy authorities
-
1.2.1.5 Subject-matter experts and consultants
-
1.2.1.6 End users across both B2B and B2C segments
-
-
1.2.2 Secondary Research
-
1.2.2.1 Public data sources
-
1.2.2.2 Paid Data Sources
-
-
1.2.3 Internal Knowledge Systems
-
2 Data Validation
-
2.1 Market Engineering & Quantitative Modelling
-
2.1.1 Market Sizing and Forecasting Approach
-
2.1.1.1 Market Sizing Techniques
-
2.1.1.2 Forecasting Models
-
-
-
2.2 Economic Modelling Framework
-
2.2.1 Cost Structure & Value Chain Economics
-
2.2.2 Demand & Price Elasticity Analysis
-
2.2.3 Supply–Demand Balance Assessment
-
2.2.4 Economic Impact Assessment
-
-
2.3 Industry Structure, Competition & Technology Analysis
-
2.3.1 Tools and Approaches Applied
-
-
2.4 Validation & Sensitivity Analysis
-
2.5 Insight Development & Recommendations
-
2.6 Transparent Documentation
3 Data Presentation
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for our full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants your team direct access to our lead analysts for bespoke strategic consultation.
Latest News about Losartan Market
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://en.wikipedia.org/wiki/Healthcare_industry
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- http://: https://www.who.int/tools/atc-ddd-toolkit/data
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main